https://doi.org/10.1016/s1470-2045(22)00284-4
R
Ramachandran Venkitaraman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
2.1K
Citations
27
h-index
45
i10-index
Ramachandran Venkitaraman is an academic researcher from Hospital Clínic de Barcelona. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Voice and Speech Disorders & Dysphagia Assessment and Management. The author has an h-index of 27, co-authored 66 publications.
ORCID: 0000-0002-6296-6033Papers by this author
worksFulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial
2022 · The Lancet Oncology · 139 citations
Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features
2010 · Expert Review of Anticancer Therapy · 89 citations
https://doi.org/10.1586/era.09.189
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
2024 · Nature · 41 citations
https://doi.org/10.1038/s41586-024-07384-2
A single institution experience of combined modality management of extra skeletal Ewings sarcoma
2007 · World Journal of Surgical Oncology · 38 citations
https://doi.org/10.1186/1477-7819-5-3
Prognosis of Patients with Triple-negative Breast Cancer and Brain Metastasis
2009 · Clinical Oncology · 12 citations
https://doi.org/10.1016/j.clon.2009.07.002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat